Peter Hillmen
Leeds Teaching Hospitals NHS Trust(GB)Apellis Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Complement system in diseases, Immunodeficiency and Autoimmune Disorders, Blood groups and transfusion
Most-Cited Works
- → SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage(2013)228 cited
- → Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency(2006)222 cited
- → Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization(2010)190 cited
- → Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease(2023)144 cited
- → Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia(2009)110 cited
- → IMPLICATIONS OF RECENT INSIGHTS INTO THE PATHOPHYSIOLOGY OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA(2000)77 cited